Medicine and Dentistry
Intraocular Pressure
100%
Aqueous Humor Flow
91%
Diabetic Macular Edema
38%
Disease
34%
Visual Acuity
33%
Ocular Hypertension
32%
Optical Coherence Tomography
29%
Cataract
28%
Aqueous Humor Outflow
27%
Aflibercept
25%
Ranibizumab
24%
Agents Acting on the Eye
24%
Age Related Macular Degeneration
22%
Schlemm's Canal
21%
Epithelial Cell
20%
Glaucoma
20%
Osteolysis
19%
Anterior Chamber of Eyeball
18%
Pediatrics
18%
Best Corrected Visual Acuity
17%
Diabetic Retinopathy
17%
Latanoprost
16%
Crystallin
16%
Simvastatin
16%
Uveitis
15%
Fluorophotometry
15%
Retinopathy of Prematurity
15%
Venous Pressure
15%
Brimonidine
14%
Prodrug
14%
Open Angle Glaucoma
14%
Retinal Pigment Epithelium
14%
Antioxidant
14%
Alveolar Bone
13%
Choroidal Neovascularization
13%
Peroxiredoxin 6
13%
Closed Head Injury
13%
Dexamethasone
12%
Protein A
12%
Randomized Clinical Trial
12%
Contralateral
12%
Injury
12%
Retinal Haemorrhage
12%
Drug Therapy
11%
Oxidative Stress
11%
Quality of Life
11%
Vitreous
11%
Volunteer
11%
Biometry
10%
Student T Test
10%
Photoreceptor
10%
Retinopathy
10%
Edema
10%
Stem Cell
10%
Virus Infection
10%
Diagnosis
10%
Pediatric Ophthalmology
10%
Spectral Domain Optical Coherence Tomography
10%
Prevalence
9%
Visual Impairment
9%
Diabetes Mellitus
9%
Vasculotropin
9%
Eye Disease
9%
Neural Stem Cell
9%
Vascular Disease
9%
Visual Pigment
9%
Bone Regeneration
9%
Travoprost
9%
Hyperopia
9%
Calcium Ion
9%
Geographic Atrophy
9%
Carcinogenesis
9%
Lens Fiber
9%
Programmed Cell Death
9%
Strabismus
9%
Trabecular Meshwork
9%
Reactive Oxygen Species
9%
Choroid
9%
Optic Nerve
8%
Clinical Trial
8%
Cell Death
8%
Epileptic Absence
8%
Cataractogenesis
8%
Acute Retinal Necrosis
8%
Symptom
8%
Infection
8%
Surgery
8%
Fluorescein Angiography
8%
Glaucoma Surgery
8%
Timolol
8%
Placebo
8%
Wet Macular Degeneration
8%
Nanofiber
8%
Implant
7%
Diabetes
7%
Traumatic Brain Injury
7%
Basement Membrane
7%
Odds Ratio
7%
Small Heat Shock Protein
7%
Ebolavirus
7%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Macular Edema
47%
Disease
47%
Uveitis
45%
Aflibercept
44%
Ranibizumab
41%
Prodrug
41%
Mouse
40%
Dexamethasone
40%
N (2 Hydroxypropyl)methacrylamide Copolymer
32%
Diabetic Retinopathy
30%
Age Related Macular Degeneration
26%
Vasculotropin
26%
Adverse Event
25%
Inflammation
22%
Glucocorticoid
22%
Rheumatoid Arthritis
22%
Glaucoma
22%
Cataract
21%
Wet Macular Degeneration
20%
Clinical Trial
20%
Latanoprost
20%
Antioxidant
18%
Intraocular Hypertension
18%
Biodistribution
16%
Simvastatin
16%
Rapamycin
16%
Diabetes Mellitus
16%
Pharmacokinetics
14%
Calcium Ion
14%
Retrolental Fibroplasia
14%
Mouse Model
13%
Timolol
13%
Experimental Periodontitis
13%
Copolymer
13%
Alendronic Acid
13%
Micelle
13%
Lupus Erythematosus Nephritis
13%
Nanomedicine
13%
Visual Pigment
12%
Macaca fascicularis
12%
Haplorhini
11%
Periodontitis
11%
Pharmacotherapy
11%
Aldehyde Reductase
11%
Cyclodextrin
11%
Randomized Clinical Trial
11%
Combination Therapy
11%
Macular Edema
11%
Edema
11%
Subretinal Neovascularization
10%
Retinopathy
10%
Prostaglandin
10%
Randomized Controlled Trial
10%
Receptor Agonist
9%
Brimonidine
9%
Phosphatase
9%
Bimatoprost
9%
Ocular Drug
9%
Hypermetropia
9%
Drug Delivery System
9%
Hydroxyapatite
9%
Transcription Factor Nrf2
9%
Nitric Oxide
9%
Vascular Disease
9%
Peroxiredoxin 6
9%
Adjuvant Arthritis
8%
Adjuvant-Induced Arthritis
8%
Side Effect
8%
Cataractogenesis
8%
Strabismus
8%
Rat Model
8%
Syndrome
8%
Prostanoid Receptor
8%
Lens Epithelium Derived Growth Factor
7%
Visual Impairment
7%
Transforming Growth Factor
7%
Cross-Sectional Study
7%
Carcinogenesis
7%
Travoprost
7%
Metastatic Melanoma
7%
Neovascularization (Pathology)
6%
Eye Disease
6%
Dutch Belted (Rabbit)
6%
Fluorescein
6%
Epileptic Absence
6%
Triamcinolone Acetonide
6%
Geographic Atrophy
6%
Acetazolamide
6%
Liposome Targeting
6%
Platelet Derived Growth Factor
6%
Janus Kinase Inhibitor
6%
Lysophosphatidic Acid
6%
Nanocarrier
6%
Ulcerative Colitis
6%
Aldose Reductase Inhibitor
6%
Uvea Melanoma
6%
Retina Degeneration
6%
Divergent Strabismus
6%
Nanoparticle
6%
Amblyopia
6%
Keyphrases
Intraocular Pressure
36%
Aqueous Humor Dynamics
29%
SUMOylation
28%
Outflow Facility
24%
Glaucoma
21%
Oxidative Stress
17%
Uveoscleral Outflow
17%
Ribbon
17%
Ribbon Synapse
16%
PRDX6
16%
Ocular Hypertension
15%
Synaptic Ribbon
15%
Aqueous Flow
15%
Diabetic Macular Edema
14%
Lens Epithelial Cells
14%
Photoreceptor
13%
Uveitis
13%
Latanoprost
12%
Non-infectious Uveitis
12%
Retina
12%
Visual Pathway
12%
Vertebrate Retina
11%
Timolol
11%
Peroxiredoxin 6
11%
Aging Stresses
10%
Photoreceptor Synapse
10%
Diabetic Retinopathy
10%
Aqueous Humor Outflow
10%
Replenishment
10%
Age-related Macular Degeneration
9%
Ca2+
9%
Blind People
9%
Artificial Vision
9%
Nerve Prosthesis
9%
Vision Devices
9%
Hypertensive Patients
9%
Intravitreal Aflibercept Injection
9%
Lens Epithelium-derived Growth Factor
9%
Vesicle Pools
9%
Rod Photoreceptor
9%
Visual Outcome
9%
Synaptic Transmission
9%
Ranibizumab
9%
Diabetes
9%
Monkey
8%
Brimonidine
8%
Synapse
8%
Aldose Reductase Inhibitor
8%
Retinal pigment Epithelium
8%
Aging
8%
Best-corrected Visual Acuity
8%
Retinal Ganglion Cells
8%
Glia
8%
Optic Nerve
8%
Exocytosis
7%
Triamcinolone Acetonide
7%
Releasable
7%
Receptor Agonist
7%
Lens Opacity
7%
Human Eye
7%
Randomized Clinical Trial
7%
High Dose
7%
Phase II Study
7%
Laser-induced
7%
Fluorophotometry
6%
Lupus Nephritis
6%
Antioxidant System
6%
Uveitic Macular Edema
6%
Apraclonidine
6%
Optical Coherence Tomography
6%
Glutamate
6%
Phosphorylation
6%
Neurogenic Potential
6%
Notch Signaling
6%
Prostaglandins
6%
Geographic Atrophy
6%
Crystallin Gene
6%
Retinal Sensitivity
6%
Syndrome Type
6%
Central Corneal Thickness
6%
Scleritis
6%
Intravitreal Aflibercept
6%
Intraocular Lens
6%
Prodrug Nanomedicine
6%
Asteroid Bodies
6%
Eye Diseases
6%
Phosphatase 2A
6%
Surgical Table
6%
Galactose
6%
Suprachoroidal
6%
Growth Factor Inhibitors
6%
PP-1
6%
L-phenylglycine
6%
Eye Development
6%
HSPB5
6%
Macula
6%
Murine Lupus
6%
Sirolimus
6%
Retinal Biopsy
6%
Vitreoretinal Lymphoma
6%